Literature DB >> 8364573

A microsatellite-based index map of human chromosome 11.

M Litt1, P Kramer, X Y Hauge, J L Weber, Z Wang, P J Wilkie, M S Holt, S Mishra, H Donis-Keller, L Warnich.   

Abstract

We have constructed a continuous index map of 25 microsatellite markers on human chromosome 11. The markers have been typed in 40 CEPH families, have heterozygosities of 69% or higher and can be typed by PCR. The odds against inversion of adjacent marker loci order are at least 10(5):1. The sex average map covers a total of 162 cM with no gap exceeding 15 cM. Total lengths for female and male maps are 205 and 123 cM, respectively. By use of a hybrid cell panel or by in situ hybridization, 16 of the markers have also been mapped cytogenetically, providing a good correlation of the index map with the cytogenetic map. The map will facilitate high resolution mapping of additional polymorphic loci and of disease genes on chromosome 11.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364573     DOI: 10.1093/hmg/2.7.909

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Localization of Romano-Ward long QT syndrome gene, LQT1, to the interval between tyrosine hydroxylase (TH) and D11S1349.

Authors:  M W Russell; M Dick; R M Campbell; J E Hulse; D J Munroe; E Bric; D E Housman; F S Collins; L C Brody
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

2.  High-resolution meiotic and physical mapping of the best vitelliform macular dystrophy (VMD2) locus to pericentromeric chromosome 11.

Authors:  B H Weber; G Vogt; H Stöhr; S Sander; D Walker; C Jones
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

3.  Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse.

Authors:  D J Symula; A Shedlovsky; W F Dove
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

4.  Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.

Authors:  S Iyengar; H Kalinsky; S Weiss; M Korostishevsky; M Sadeh; Y Zhao; K K Kidd; B Bonne-Tamir
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium.

Authors:  E Lange; A L Borresen; X Chen; L Chessa; S Chiplunkar; P Concannon; S Dandekar; S Gerken; K Lange; T Liang
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

6.  Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant.

Authors:  C M Smith; S A Wells; D S Gerhard
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

7.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24.

Authors:  G M Hampton; L A Penny; R N Baergen; A Larson; C Brewer; S Liao; R M Busby-Earle; A W Williams; C M Steel; C C Bird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Genetic linkage analyses of Romano-Ward syndrome (RWS) in 13 Japanese families.

Authors:  T Tanaka; K Nakahara; N Kato; T Imai; T Yamazaki; H Tomita; H Shimokawa; H Matsuhashi; N Sato; M Matsui
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

9.  Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy.

Authors:  P M Thomas; G J Cote; D M Hallman; P M Mathew
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity.

Authors:  E C Mariman; S E van Beersum; C W Cremers; P M Struycken; H H Ropers
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.